16-57565096-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001304376.3(ADGRG5):c.492C>A(p.His164Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000044 in 1,613,832 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001304376.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADGRG5 | NM_001304376.3 | c.492C>A | p.His164Gln | missense_variant | 6/12 | ENST00000349457.8 | NP_001291305.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADGRG5 | ENST00000349457.8 | c.492C>A | p.His164Gln | missense_variant | 6/12 | 1 | NM_001304376.3 | ENSP00000290823 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152094Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000716 AC: 18AN: 251430Hom.: 1 AF XY: 0.0000957 AC XY: 13AN XY: 135892
GnomAD4 exome AF: 0.0000383 AC: 56AN: 1461738Hom.: 1 Cov.: 30 AF XY: 0.0000468 AC XY: 34AN XY: 727186
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152094Hom.: 0 Cov.: 32 AF XY: 0.000148 AC XY: 11AN XY: 74286
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 28, 2022 | The c.492C>A (p.H164Q) alteration is located in exon 6 (coding exon 5) of the ADGRG5 gene. This alteration results from a C to A substitution at nucleotide position 492, causing the histidine (H) at amino acid position 164 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at